3//SEC Filing
Fosun Pharma USA Inc. 3
Accession 0001140361-25-021964
CIK 0000275053other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:32 PM ET
Size
4.2 KB
Accession
0001140361-25-021964
Insider Transaction Report
Form 3
Fosun Pharma USA Inc.
10% Owner
Holdings
- 2,854,607
Common Stock
Footnotes (1)
- [F1]. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. transferred these shares to its wholly-owned subsidiary, Fosun Pharma USA Inc. Following the transfer, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and Fosun Pharma USA Inc. intend to jointly file Section 16 reports with respect to these shares.
Documents
Issuer
NATURES SUNSHINE PRODUCTS INC
CIK 0000275053
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0002071437
Filing Metadata
- Form type
- 3
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:32 PM ET
- Size
- 4.2 KB